Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TGFB1 Antikörper

TGFB1 Reaktivität: Human, Schaf WB, IHC (p), IHC (fro), EIA, Func Wirt: Maus Monoclonal TB21 unconjugated
Produktnummer ABIN114558
  • Target Alle TGFB1 Antikörper anzeigen
    TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
    Reaktivität
    • 167
    • 103
    • 50
    • 22
    • 20
    • 15
    • 12
    • 11
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Human, Schaf
    Wirt
    • 192
    • 43
    • 3
    • 2
    • 1
    • 1
    Maus
    Klonalität
    • 195
    • 46
    Monoklonal
    Konjugat
    • 97
    • 36
    • 32
    • 13
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 1
    Dieser TGFB1 Antikörper ist unkonjugiert
    Applikation
    • 181
    • 94
    • 69
    • 53
    • 52
    • 42
    • 35
    • 34
    • 30
    • 19
    • 18
    • 11
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA), Functional Studies (Func)
    Spezifität
    This antibody detects Transforming Growth Factor beta/TGF beta.
    Aufreinigung
    Affinity Chromatography on Protein G.
    Immunogen
    TGF-beta from Human platelets.
    Klon
    TB21
    Isotyp
    IgG1
    Top Product
    Discover our top product TGFB1 Primärantikörper
  • Applikationshinweise
    ELISAThis antibody recognizes both Human platelet-derived and recombinant TGF-beta in ELISA. Functional AssayThis antibody neutralizes TGF-beta activity in vitro, in an inhibition assay of CCL/64 cellgrowth and neutralizes the growth promoting action of TGF-beta in the NRK-49F colonyforming assay. The effect of micro-injection of this antibody into one blastomere of two cellstage Xenopus embryos indicated that it was able to neutralize effectively the bioactivity ofTGF-beta in vivo. Immunohistochemistry on FFPE and Frozen SectionsThis antibody has been used to demonstrate TGF-beta in ovine ovarian tissue and humanbreast carcinoma at a dilution of 1: 1000. As a consequence of the intense staining of theerythrocytes it is possible to locate a single cell within the ovarian stroma making it usefulin locating very fine capillary networks within tissue. Western Blotting5-20 ng/mL will allow visualization of 100 ng/lane of TGF-beta. Reacts with dimeric (25 Kd)
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Rekonstitution
    Restore in 0.5 mL double distilled water.
    Konzentration
    1.0 mg/mL
    Buffer
    0.01 M PBS, pH 7.0 without preservatives.
    Konservierungsmittel
    Without preservative
    Handhabung
    This product is photosensitive and should be protected from light
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store the antibody at 2 - 8 °C. DO NOT FREEZE!
  • Moesgaard, Aupperle, Rajamäki, Falk, Rasmussen, Zois, Olsen: "Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-? (TGF-?) in advanced canine myxomatous mitral valve disease." in: Research in veterinary science, Vol. 97, Issue 3, pp. 560-7, (2015) (PubMed).

    Yue, Goldstein, Hollingsworth, Kaul, Brand, Haab: "The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays." in: Molecular & cellular proteomics : MCP, Vol. 8, Issue 7, pp. 1697-707, (2009) (PubMed).

    Bukowska, Lendeckel, Krohn, Keilhoff, ten Have, Neumann, Goette: "Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney." in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 10, Issue 10, pp. 1212-7, (2008) (PubMed).

    Aupperle, März, Thielebein, Schoon: "Expression of transforming growth factor-beta1, -beta2 and -beta3 in normal and diseased canine mitral valves." in: Journal of comparative pathology, Vol. 139, Issue 2-3, pp. 97-107, (2008) (PubMed).

    Jaeger, Koczan, Thiesen, Ibrahim, Gross, Spang, Kunz: "Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 3, pp. 806-15, (2007) (PubMed).

    Richter, Hayden-Ledbetter, Irgang, Ledbetter, Westermann, Körner, Daemen, Clark, Aicher, Pezzutto: "Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells." in: The Journal of biological chemistry, Vol. 276, Issue 49, pp. 45686-93, (2002) (PubMed).

  • Target
    TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
    Andere Bezeichnung
    TGFB1 (TGFB1 Produkte)
    Synonyme
    CED antikoerper, DPD1 antikoerper, LAP antikoerper, TGFB antikoerper, TGFbeta antikoerper, TGF-beta antikoerper, TGF-BETA-1 antikoerper, TGF-beta5 antikoerper, ced antikoerper, dpd1 antikoerper, lap antikoerper, tgf-beta antikoerper, tgfb antikoerper, tgfb5 antikoerper, tgfbeta antikoerper, TGF-beta1 antikoerper, TGFbeta1 antikoerper, Tgfb antikoerper, Tgfb-1 antikoerper, ai39657 antikoerper, tgfb1 antikoerper, wu:fb13a07 antikoerper, xx:ai39657 antikoerper, TGFB1 antikoerper, csd antikoerper, cdb1 antikoerper, cdg2 antikoerper, csd1 antikoerper, csd2 antikoerper, csd3 antikoerper, ebmd antikoerper, lcd1 antikoerper, bigh3 antikoerper, cdgg1 antikoerper, betaig-h3 antikoerper, TGFB4 antikoerper, transforming growth factor beta 1 antikoerper, transforming growth factor beta-1 antikoerper, transforming growth factor beta 1 L homeolog antikoerper, transforming growth factor, beta 1 antikoerper, transforming growth factor, beta 1a antikoerper, transforming growth factor beta induced L homeolog antikoerper, TGFB1 antikoerper, Tgfb1 antikoerper, tgfb1.L antikoerper, tgfb1a antikoerper, tgfbi.L antikoerper
    Hintergrund
    TGF beta 1 (Transforming Growth Factor Beta 1) is a multifunctional peptide capable of influencing cell proliferation, differentiation, and other functions in a wide range of cell types. Transformed as well as non neoplastic tissues, release transforming growth factors, and essentially all cells possess a specific TGF beta 1 receptor. The multimodal nature of TGF beta 1 is seen in its ability to stimulate or inhibit cellular proliferation. TGF beta 1 plays a fundamental role in tissue growth and differentiation involvement in adipogenesis, myogenesis, chondrogenesis, osteogenesis, epithelial cell differentiation and immune cell function. The C-terminal 112 amino acids constitute the mature protein.Synonyms: TGF-beta-1, TGFB, Transforming growth factor beta-1
    Gen-ID
    7040
    NCBI Accession
    NP_000651
    UniProt
    P01137
    Pathways
    EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice